Biosimilar medicines critical for future medicines access and sustainability but more biologic competition is needed in the EU

13 December 2023

(Original in SK) How low pricing of generic and biosimilar drugs relates to their shortage

27 November 2023

OPEN LETTER: Members of the European Parliament and EU 27 Ministers of Health on the revision of the pharmaceutical legislation

8 November 2023

Now or never: Europe must seize the Pharma Legislation opportunity to ensure patient access to continuous innovation for existing medicines

7 November 2023

New IQVIA report points to window of opportunity for the EU to foster future-proof biosimilar competition

26 October 2023

Reformed SPC regulation would enhance timely access to essential medicines

25 October 2023

A step forward for the secure supply of medicines and manufacturing and for public health

25 October 2023

New pricing models for generic medicines to ensure long-term sustainable competition in Europe

10 October 2023

Background: Price erosion of generic medicines over time as a […]

Time for the EU to take steps: a medicines security act is needed for health security

2 October 2023

A streamlined, digital regulatory framework is the foundation for equitable access to medicines

27 September 2023